SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Arix Bioscience plc. (2/28/18). "Press Release: Proposed Firm Placing, Placing and Offer [Not for United States, Australia, Canada, Japan, New Zealand, The Republic of Ireland or the Republic of South Africa or other Jursidcitions Where Unlawful]".

Organisations Organisation Arix Bioscience plc (LSE: ARIX)
  Today Arix Bioscience (Group)
  Group Arix Bioscience (Group)
  Organisation 2 London Stock Exchange (LSE)
Products Product venture capital
  Product 2 investment banking
Index term Index term Arix Bioscience–SEVERAL: investment, 201802–201803 capital increase £87m with 38.6m new ordinary shares to new + existing investors
Persons Person Anderson, Joe (Arix Bioscience 201809– Chief Investment Officer before CEO before Abingworth)
  Person 2 Milligan, Ivar (Consilium 201705)

Record changed: 2018-03-29


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Arix Bioscience (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUK] – The Business Web Portal 600x80px

» top